euro adhoc: Sartorius AG / other / Ad-hoc-Announcement according to section 15 of the German WpHG / Sartorius AG will not take Vivascience AG public (E)

Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement.

The Executive Board and the Supervisory Board of Sartorius AG and Vivascience AG decided not to carry out an IPO of Vivascience AG that had originally been planned for 2001 and then postponed indefinitely. The Sartorius Group’s conviction about the business model and growth opportunities of this business area remains unchanged. However, considering the current capital market environment, the Group does not see any possibility to realize profits from an IPO that would sufficiently reflect this growth potential. Rather, this business area is to be further expanded within the Sartorius Group and the available synergies are to be increasingly used. The decision taken does not have any impact on the sales revenue and earnings targets of the Sartorius Group.

Further inquiry note:
Heiko Imoehl
VP Treasury & Investor Relations
+49 551 308 4034

emitter: Sartorius AG Weender Landstr. 94-108 D-37075 Göttingen phone: +49 (0)551 308 0 FAX: +49 (0)551 308 289 mail: WWW: ISIN: DE0007165607, DE0007165631

end of announcement euro adhoc


sector: Biotechnology language: English